chr19-40599248-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000204005.13(LTBP4):c.68C>T(p.Ala23Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,613,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A23A) has been classified as Likely benign.
Frequency
Consequence
ENST00000204005.13 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LTBP4 | NM_003573.2 | c.68C>T | p.Ala23Val | missense_variant | 2/33 | ||
LTBP4 | NM_001042544.1 | c.198C>T | p.Cys66= | synonymous_variant | 2/33 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LTBP4 | ENST00000204005.13 | c.68C>T | p.Ala23Val | missense_variant | 2/33 | 1 | A2 | ||
LTBP4 | ENST00000308370.11 | c.198C>T | p.Cys66= | synonymous_variant | 2/33 | 1 | A2 | ||
LTBP4 | ENST00000594537.2 | c.146C>T | p.Ala49Val | missense_variant, NMD_transcript_variant | 2/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000564 AC: 14AN: 248074Hom.: 0 AF XY: 0.0000520 AC XY: 7AN XY: 134646
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461314Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 726902
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74370
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.68C>T (p.A23V) alteration is located in exon 2 (coding exon 2) of the LTBP4 gene. This alteration results from a C to T substitution at nucleotide position 68, causing the alanine (A) at amino acid position 23 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 14, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 23 of the LTBP4 protein (p.Ala23Val). This variant is present in population databases (rs200001868, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with LTBP4-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at